Tempus Completes Acquisition of Ambry Genetics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- US stock futures up as chip shares recover, oil prices decline
- Oil falls after OPEC+ agrees to raise output targets
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
TD Cowen Reinstates Tempus AI Inc (TEM) at Buy
February 5, 2025 7:00 AM ESTTD Cowen analyst Dan Brennan reinstates coverage on Tempus AI Inc (NASDAQ: TEM) with a Buy rating and a price target of $74.00.
The analyst comments "TEM closed its Ambry acquisition & we reinstate coverage with Buy. The deal affords TEM w/ a $300M+, profitable... More
